Provided by Tiger Trade Technology Pte. Ltd.

Novo-Nordisk A/S

44.01
-0.5500-1.23%
Pre-market: 43.46-0.5500-1.25%05:21 EDT
Volume:6.58M
Turnover:291.64M
Market Cap:196.50B
PE:10.99
High:44.82
Open:44.60
Low:44.01
Close:44.56
52wk High:64.16
52wk Low:35.12
Shares:4.47B
Float Shares:3.19B
Volume Ratio:0.69
T/O Rate:0.21%
Dividend:1.72
Dividend Rate:3.91%
EPS(TTM):4.00
EPS(LYR):3.62
ROE:59.82%
ROA:18.73%
PB:6.03
PE(LYR):12.16

Loading ...

Novo Nordisk CEO Remains Open to Bolt-on Acquisitions, but Rules Out Transformative Deals

Dow Jones
·
Aug 05

Eli Lilly raises annual revenue forecast as GLP-1 drugs fuel growth

Bloomberg
·
Aug 05

UBS Keeps Their Hold Rating on Novo Nordisk (0QIU)

TIPRANKS
·
Aug 05

Novo-Nordisk CEO Defends Wegovy Oral Pill Amid Pricing Pressure, Shares Slide on Sales Concern

Deep News
·
Aug 05

Movement Alert|Novo-Nordisk A/S Pre-Market Rise 5.04%, Q2 Earnings Beat Expectations with Full-Year Guidance Raised

Market Focus
·
Aug 05

European Stocks Extend Record Highs

Dow Jones
·
Aug 05

Movement Alert|Novo-Nordisk A/S Rises 3.14% Overnight, Q2 Earnings Beat Expectations as Management Signals Confidence in GLP-1 Growth

Market Focus
·
Aug 05

Novo Nordisk Shares Likely to Fall at Open, but Less than in U.S. Session

Dow Jones
·
Aug 05

Novo Nordisk A/S Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 05

Novo Nordisk Earnings Beat but Study Data, Wegovy Pill Sales Underwhelm

Dow Jones
·
Aug 05

Dow Jones Top Company Headlines at 7 PM ET: SpaceX Revenue Could Reach $1 Trillion, Elon Musk Says | Paramount's ...

Dow Jones
·
Aug 05

Novo Nordisk Q2 Adj. EPS $0.96 Beats $0.81 Estimate, Sales $12.209B Beat $11.350B Estimate

Benzinga Earnings
·
Aug 05

The Wegovy Pill's 'surprise Miss' is One Reason Novo Nordisk's Stock is Down

Dow Jones
·
Aug 05

Wegovy Maker Novo Nordisk Lifts Annual Forecast Amid Rising Demand for Weight-Loss Drugs

Deep News
·
Aug 05

Novo Nordisk Raises Earnings Guidance. the Stock Sinks.

Dow Jones
·
Aug 05

Wegovy-Maker Novo Nordisk Raises Full-Year Guidance as Appetite for Weight-Loss Drugs Grows

Dow Jones
·
Aug 05

Novo Nordisk Lifts 2026 Outlook After Strong Q2 Adjusted Results

TIPRANKS
·
Aug 05

Novo Nordisk Q2 Lifts FY Guidance on Stronger GLP-1 Demand

Reuters
·
Aug 05

Novo Nordisk Boosts Adjusted Sales, Operating Profit Guidance for 2026

MT Newswires Live
·
Aug 05

Novo Nordisk reports Q2 adjusted sales DKK 78.49B, up 7% at CER

TIPRANKS
·
Aug 05